These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 203952)

  • 1. Effect of the extractive heparinoid, glucuronylglucosaminglycan sulfate (3-GS), on human plasma lipids.
    Avogaro P; Bittolo BG; Taroni GC; Cazzolato G; Belussi F
    Pharmacol Res Commun; 1977 Nov; 9(10):977-86. PubMed ID: 203952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P; Terlizzi N
    Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia.
    Mabuchi H; Tatami R; Ueda K; Ueda R; Haba T; Kametani T; Watanabe A; Wakasugi T; Ito S; Koizumi J; Ohta M; Miyamoto S; Takeda R
    Atherosclerosis; 1979 Apr; 32(4):435-44. PubMed ID: 223596
    [No Abstract]   [Full Text] [Related]  

  • 4. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA; Penttilä IM; Lampainen E
    Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low density lipoprotein cholesterol levels in the blood of healthy and hyperlipemic men 40--59-years-old].
    Vinogradov AG; Shcherbakova IA
    Kardiologiia; 1982 Aug; 22(8):26-30. PubMed ID: 7132037
    [No Abstract]   [Full Text] [Related]  

  • 6. On a family with coexistence of phenotypes II and III hyperlipoproteinemia.
    Mariën KJ; Hulsmans HA; van Gent CM
    Acta Med Scand; 1974 Sep; 196(3):149-53. PubMed ID: 4370577
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Differential diagnosis of hyperlipoproteinemia using simultaneous determination of the lipids of the beta-prebeta lipoprotein group and of the lipid (beta and pre-beta)-cholesterol ratio].
    Girard ML; Delattre J; Legrand A; Canal J
    Ann Biol Clin (Paris); 1973; 31(2):91-3. PubMed ID: 4356118
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man.
    Boberg J; Carlson LA; Fröberg SO; Orö L
    Atherosclerosis; 1970; 11(2):353-60. PubMed ID: 4353910
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laboratory study of dyslipidemias and dyslipoproteinemias].
    Mihalache N; Georgescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1974; 26(8):905-13. PubMed ID: 4157095
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(2):337-46. PubMed ID: 4360244
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein-lipid quantification by neural-network analysis of 1H NMR data from human blood plasma.
    Hiltunen Y; Heiniemi E; Ala-Korpela M
    J Magn Reson B; 1995 Feb; 106(2):191-4. PubMed ID: 7850187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characterization of pre-beta hyperlipoproteinemias using 3 methods of electrophoresis].
    Michaux A; Rouffy J; Loeper J; Dreux C
    Ann Biol Clin (Paris); 1973; 31(2):95-6. PubMed ID: 4356119
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia.
    Ciświcka-Sznajderman M; Berent H; Rymaszewski Z
    Atherosclerosis; 1974; 19(1):153-9. PubMed ID: 4359182
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the flotation phenomenon in the determination of beta-lipoproteins by the immunocrit method.
    Tamachi H; Suzuki H; Ohsawa Y; Matsumiya H
    Clin Chim Acta; 1976 Apr; 68(2):195-8. PubMed ID: 177233
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 19. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of lipoproteins and lipoprotein disorders.
    Lewis B
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():26-31. PubMed ID: 4354845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.